Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database.
Saved in:
| Title: | Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database. |
|---|---|
| Authors: | Dreikhausen L; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lena.dreikhausen@umm.de., Olkus A; Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Dill M; Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany., Heumann P; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany., Schulte N; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Atanasova K; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Ebert MP; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany., Letsch A; Department of Internal Medicine II, University Hospital Center Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein, Kiel, Germany., Wandmacher AM; Department of Internal Medicine II, University Hospital Center Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein, Kiel, Germany.; Group of Inflammatory Carcinogenesis, Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein (UKSH), Kiel University, Kiel, Germany., Zhan T; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Tianzuo.zhan@umm.de.; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. Tianzuo.zhan@umm.de.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Tianzuo.zhan@umm.de.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany. Tianzuo.zhan@umm.de. |
| Source: | Targeted oncology [Target Oncol] 2026 May; Vol. 21 (3), pp. 411-420. Date of Electronic Publication: 2026 Apr 20. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42010184 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dreikhausen+L%22">Dreikhausen L</searchLink>; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. lena.dreikhausen@umm.de.<br /><searchLink fieldCode="AU" term="%22Olkus+A%22">Olkus A</searchLink>; Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Dill+M%22">Dill M</searchLink>; Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; German Cancer Research Center (DKFZ) Heidelberg, Experimental Hepatology, Inflammation and Cancer, Heidelberg, Germany.; Liver Cancer Center Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Springfeld+C%22">Springfeld C</searchLink>; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heumann+P%22">Heumann P</searchLink>; Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schulte+N%22">Schulte N</searchLink>; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Atanasova+K%22">Atanasova K</searchLink>; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Ebert+MP%22">Ebert MP</searchLink>; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Letsch+A%22">Letsch A</searchLink>; Department of Internal Medicine II, University Hospital Center Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Wandmacher+AM%22">Wandmacher AM</searchLink>; Department of Internal Medicine II, University Hospital Center Schleswig-Holstein, Kiel, Germany.; University Cancer Center Schleswig-Holstein, Kiel, Germany.; Group of Inflammatory Carcinogenesis, Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein (UKSH), Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Zhan+T%22">Zhan T</searchLink>; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Tianzuo.zhan@umm.de.; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany. Tianzuo.zhan@umm.de.; Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Tianzuo.zhan@umm.de.; Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, Heidelberg, Germany. Tianzuo.zhan@umm.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2026 May; Vol. 21 (3), pp. 411-420. <i>Date of Electronic Publication: </i>2026 Apr 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42010184 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11523-026-01211-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 411 Titles: – TitleFull: Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dreikhausen L – PersonEntity: Name: NameFull: Olkus A – PersonEntity: Name: NameFull: Dill M – PersonEntity: Name: NameFull: Springfeld C – PersonEntity: Name: NameFull: Heumann P – PersonEntity: Name: NameFull: Schulte N – PersonEntity: Name: NameFull: Atanasova K – PersonEntity: Name: NameFull: Ebert MP – PersonEntity: Name: NameFull: Letsch A – PersonEntity: Name: NameFull: Wandmacher AM – PersonEntity: Name: NameFull: Zhan T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1776-260X Numbering: – Type: volume Value: 21 – Type: issue Value: 3 Titles: – TitleFull: Targeted oncology Type: main |
| ResultId | 1 |